Scholars Central

Conference abstract

Chitosan nanoparticles - Challenges for antibiotic drug delivery using Penicillin as a model drug

Authors: B B Barik, Mohammed M Safhi, S.M.Sivakumar, Aamena Jabeen, Foziyah zakir, Farah Islam

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Antibiotic resistance is one of the major health problems worldwide. Resistance to penicillin is well recognized in Staphylococcus aureus and Staphylococcus epidermidis. During last decade various resistance mechanisms such as decreased uptake, increased efflux of drug from bacterial cell, formation of biofilms to avoid contact with antibiotics have been identified that lead to failure in the treatment. The concept of drug delivery system is rapidly moving towards the development of biodegradable polymeric nanoparticles. For past two decades many researchers have been developing nanoparticle drug delivery especially delivering of anticancer drugs and vaccines. The main advantage of this system is to deliver drug moiety at the site of cell that can improve pharmacokinetic and pharmacodynamic profiles of the drug. Thus the nanoparticles improve solubility, stability and bioavailability of various drugs. However, it is limited by toxic profile. Therefore, nanoparticle drug delivery system is highly challengeable for researchers to overcome toxicity. The application of nanoparticle in the field of Medicine and Pharmaceuticals will be exposed more and more in near future. In our study, the antibacterial efficacy of penicillin loaded chitosan nanoparticles was evaluated against selected bacterial strains namely Staphylococcus aureus, Streptococcus pyogenes, Bacillus subtilis, Escherichia coli and Klebsiella planticola of clinical origin. The study suggested that penicillin nanoparticles showed better antibiotic delivery system than conventional penicillin. However, the study is still under process in order to overcome lacunae that we experienced in our earlier studies.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutica Analytica Acta
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “B B Barik”
  • BylineArticles whose byline prints “Mohammed M Safhi”
  • BylineArticles whose byline prints “S.M.Sivakumar”
  • BylineArticles whose byline prints “Aamena Jabeen”
  • BylineArticles whose byline prints “Foziyah zakir”
  • BylineArticles whose byline prints “Farah Islam”